Udgirkar Suhas, Jain Samit, Pawar Sunil, Chandnani Sanjay, Contractor Qais, Rathi Pravin
Department of Gastroenterology, Topiwala National Medical College and B.Y.L Nair Charity Hospital, Mumbai 400008, Maharashtra, India.
Arq Gastroenterol. 2019 Aug 13;56(2):178-183. doi: 10.1590/S0004-2803.201900000-35.
Abdominal tuberculosis is an increasing problem in developing world.
The objective of the study was to describe the clinical presentations, drug resistance pattern and treatment outcomes of abdominal tuberculosis in Western India.
All the cases of abdominal tuberculosis from May 2014 to April 2017, diagnosed on the basis of clinical profile and gross morphological findings at endoscopy, imaging, followed by histology and/or GeneXpert and MGIT culture were included. All patients received antitubercular drug (AKT) therapy according to national protocol. Patients were followed from diagnoses till completion of treatment and various parameters were studied.
Out of the 176 patients, 48% were males. Abdominal pain was most common complaint in 83.5%. On colonoscopy terminal ileum and ileocaecal valve were most commonly involved segments. Upper gastrointestinal tract was involved in four patients. Overall ulceronodular lesions were most common followed by ulcerative/nodular lesion. Strictures in bowel were seen in 28 (15.9%) patients with ileocaecal valve being most commonly involved, of which 23 had symptomatic relief with AKT and only three required dilatation. Histopathology showed granuloma in 80.8% cases. MGIT was positive in 43 (35.80%) cases and GeneXpert was positive in 35 (26.1%) cases. Eight patients had multi drug resistant tuberculosis. Only two patients required surgical management.
Abdominal tuberculosis with wide spectrum of presentation, can still be managed with early diagnosis and treatment even in patients with sub acute intestinal obstruction. Weight gain or resolving symptoms were considered early markers of treatment response. Patients with stricture can become asymptomatic with medical treatment alone.
在发展中国家,腹部结核问题日益严重。
本研究旨在描述印度西部腹部结核的临床表现、耐药模式及治疗结果。
纳入2014年5月至2017年4月期间所有经临床特征、内镜检查大体形态学表现、影像学检查,随后经组织学和/或GeneXpert及MGIT培养确诊的腹部结核病例。所有患者均按照国家方案接受抗结核药物(AKT)治疗。对患者从诊断直至治疗结束进行随访,并研究各项参数。
176例患者中,48%为男性。腹痛是最常见的主诉,占83.5%。结肠镜检查显示,回肠末端和回盲瓣是最常受累的部位。4例患者上消化道受累。总体上,溃疡结节性病变最为常见,其次是溃疡性/结节性病变。28例(15.9%)患者出现肠道狭窄,其中回盲瓣最常受累,23例经AKT治疗后症状缓解,仅3例需要扩张治疗。组织病理学检查显示80.8%的病例有肉芽肿形成。MGIT检测43例(35.80%)呈阳性,GeneXpert检测35例(26.1%)呈阳性。8例患者为耐多药结核病。仅2例患者需要手术治疗。
腹部结核临床表现多样,即使是亚急性肠梗阻患者,早期诊断和治疗仍可有效管理。体重增加或症状缓解被视为治疗反应的早期指标。肠道狭窄患者单纯药物治疗可无症状。